Cipher Mining (NASDAQ: CIFR) makes most of its revenue from crypto mining, but that's about to change. The company has been signing long-term deals with tech giants that need artificial intelligence ...

Cipher Mining almost tripled its Bitcoin mining revenue and trimmed operating losses. AI is the big catalyst that can help Cipher Mining stock multiply from current levels, especially with big tech ...

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Cipher Mining (NasdaqGS:CIFR) is shifting its focus from pure bitcoin mining to ...

A high-profile investment bank launched coverage of three crypto mining stocks. It flagged two of them, including Cipher Mining, as being clear buys. According to reports the analysts generally waxed ...

Morgan Stanley initiated coverage of three publicly traded bitcoin BTC $72,799.64 mining companies on Monday, backing two names tied to data center leasing while taking a more cautious stance on a ...

NEW YORK, Feb. 09, 2026 (GLOBE NEWSWIRE) -- Cipher Mining Inc. (NASDAQ: CIFR) (“Cipher” or the “Company”) today announced it will provide a business update and release its fourth quarter and full year ...

In other recent news, Cipher Mining Inc. announced that its subsidiary, Black Pearl Compute LLC, plans to offer $2 billion in senior secured notes to finance the construction of a high-performance ...

Morgan Stanley initiated coverage on Cipher Mining and TeraWulf with Overweight ratings while downgrading Marathon to Underweight. Morgan Stanley initiated coverage of three publicly traded bitcoin ...

Investing.com - Morgan Stanley initiated coverage on Cipher Mining (NASDAQ:CIFR) with an Overweight rating and a price target of $38.00, representing a significant premium to the current stock price ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations for ...

Cipher Pharmaceuticals, Inc. engages in a diversified portfolio of commercial and early to late-stage products. It acquires products that fulfill unmet medical needs, manages the required clinical ...